Remove Allergies Remove Dermatology Remove Drugs
article thumbnail

Leo puts target on Dupixent in US as FDA clears tralokinumab

pharmaphorum

Sanofi and Regeneron have another challenger to their big-selling drug Dupixent for atopic dermatitis, now that the FDA has approved Leo Pharma’s rival antibody tralokinumab. That was enough to secure approval although it remains to be seen how well it will fare commercially against Sanofi and Regeneron’s drug.

Sales 111
article thumbnail

Senior FDA Official Dr. Julie Beitz Joins Hyman, Phelps & McNamara, P.C. as Principal Drug Regulatory Expert

FDA Law Blog

has joined the firm as a Principal Drug Regulatory Expert. Dr. Beitz served in leadership positions in FDA’s Center for Drug Evaluation and Research for nearly three decades. (“HP&M”), the largest FDA-dedicated law firm, is pleased to announce that Julie Beitz, M.D.

Drugs 49
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA clears Dupixent as first drug for rare skin disorder

pharmaphorum

Sanofi and Regeneron have claimed the first approval in the US for a drug for prurigo nodularis, after the FDA gave a green light to Dupixent as a treatment for adults with the rare skin disease following a priority review. Development in peanut allergy has also been discontinued, said Sanofi in its second-quarter update.

Drugs 69
article thumbnail

Acute itching in eczema patients linked to environmental allergens

Scienmag

Newly identified pathway explains why antihistamine drugs often don’t work to control severe itch Credit: Illustration by Madison Mack In addition to a skin rash, many eczema sufferers also experience chronic itching, but sometimes that itching can become torturous.

article thumbnail

TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress

The Pharma Data

3 These data are being presented at the 2021 European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress in Krakow, Poland and Madrid, Spain. Department of Dermatology, Venereology and Allergology, Charité – Universitätsmedizin in Berlin, Germany. No dedicated drug-drug interaction studies have been conducted.

article thumbnail

Consumer health innovation – where passion and science meet

pharmaphorum

After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families. “I I am fascinated by the breadth of my role, which encompasses self-care products, skin health, sustainability and much more.

Allergies 105
article thumbnail

Psoriasis Meds Don’t Raise Risk of Severe COVID-19: Study

The Pharma Data

Moderate-to-severe cases of psoriasis are treated with drugs that suppress the immune system. John’s Institute of Dermatology in London, who co-leads the registry. The findings were recently published online in the Journal of Allergy and Clinical Immunology. TUESDAY, Oct. ’s National Institute for Health Research.